K. Mohandas

ORCID: 0000-0001-5475-0403
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood groups and transfusion
  • Blood transfusion and management
  • Hemoglobinopathies and Related Disorders
  • Erythrocyte Function and Pathophysiology
  • Renal Transplantation Outcomes and Treatments
  • Hepatitis B Virus Studies
  • Mechanical Circulatory Support Devices
  • Parvovirus B19 Infection Studies
  • Transplantation: Methods and Outcomes
  • Platelet Disorders and Treatments
  • Neutropenia and Cancer Infections
  • Hematopoietic Stem Cell Transplantation
  • Neonatal Health and Biochemistry
  • Coleoptera: Cerambycidae studies
  • Plant Virus Research Studies
  • Insect Resistance and Genetics
  • Insect-Plant Interactions and Control
  • Lepidoptera: Biology and Taxonomy
  • Organ and Tissue Transplantation Research
  • Facial Trauma and Fracture Management
  • Atrial Fibrillation Management and Outcomes
  • Surgical site infection prevention
  • Orthoptera Research and Taxonomy
  • Head and Neck Surgical Oncology
  • Forest ecology and management

Westchester Medical Center
2006-2023

Montefiore Medical Center
1989-2018

Government Medical College and Hospital
2018

Albert Einstein College of Medicine
2003-2015

University of Washington
2001-2002

New England Research Institutes
2001-2002

New York Blood Center
2001-2002

Bloodworks Northwest
2001-2002

University of California, San Diego
2002

The Ohio State University
2002

The purpose of this study was to determine an association between packed red blood cell (PRBC) transfusions for anemia and necrotizing enterocolitis (NEC) in a subset stable, growing, premature neonates. As part survey current clinical practices over 17-month period from June 1999 October 2000, chart review performed the relationship elective PRBC occurrence NEC. Demographic data were tabulated compared NEC patients with prior history immediate transfusion (within 48 hours onset symptoms)...

10.1055/s-2006-951300 article EN American Journal of Perinatology 2006-11-01

Plasmapheresis (PP) and intravenous immunoglobulin (IVIg) remove donor-specific antibodies, a cause of acute humoral rejection (AHR). We describe the use PP IVIg as rescue therapy for AHR. The records 143 renal transplants performed between October 1, 2000 April 2002 were reviewed. Patients who underwent AHR identified. data reviewed included age, sex, source transplant, number human leukocyte antigen mismatches, transplant number, treatments, dose IVIg, time AHR, serum creatinine (SCr)...

10.1097/01.tp.0000128194.55934.48 article EN Transplantation 2004-09-07

BACKGROUND : More than 80 percent of D– patients who receive D+ blood become alloimmunized to the D antigen. Anemia occurs in most AIDS at some point disease. with may require transfusion and, during times shortage, RBCs. They would be expected d STUDY DESIGN AND METHODS The records service between January 1996 and July 2000 were reviewed for received blood. IATs performed before initial subsequently when patient required further RBC transfusion. RESULTS Eight multiple transfusions (three...

10.1046/j.1537-2995.2003.00289.x article EN Transfusion 2003-02-01

Basal skull fracture (BSF) is rare in head injury (HI) patients and occasionally goes unnoticed which may lead to cerebrospinal fluid (CSF) fistula. With changing trends HI, there a need reassess incidence pattern of BSF pattern, CSF leak, meningitis, management protocol, especially this part the world where detailed literature lacking.We closely followed adult admitted with our institute between January 2013 December 2014. Associated clinical features were recorded. In case study was done...

10.4103/jnrp.jnrp_38_18 article EN Journal of Neurosciences in Rural Practice 2018-07-01

Because antibody identification is labor-intensive, facilities with high volume and/or marginal technical support could benefit from partial automation.After a validation study of automated solid-phase red cell (RBC) adherence assay (SPRCA; Galileo, Immucor) compared to tube polyethylene glycol antiglobulin method (t-PEG), we evaluated Galileo followed by select RBC panels t-PEG. Of 298 consecutive samples in which identifications were performed 2-month period, 160 examined both and...

10.1111/j.1537-2995.2008.01736.x article EN Transfusion 2008-05-13

Erythrocytapheresis and leukapheresis (LPE) of small children are logistically complex many centres reluctant to perform these procedures. In children, both sickle cell leukaemic emergencies demand prompt action prevent additional morbidity but detailed protocols for lacking, often performed using guidelines shown work in larger patients. We report a 3-year experience with weighing 11-25 kg at large academic medical centre.All patients were treated the COBE® Spectra apheresis system; circuit...

10.1111/vox.12164 article EN Vox Sanguinis 2014-06-09

BACKGROUND: As universal leukocyte (WBC) reduction (ULR) is being considered as a new standard, few data are available on the performance of WBC‐reduction filtration in routine practice. The RBCs, using varied practices, meeting current FDA requirement (<5 × 10 6 ), Council Europe (EC) recommendation, proposed (<1 and more stringent proposal 5 ) for residual WBCs per RBC unit was assessed compared. STUDY DESIGN AND METHODS: Participating facilities were 11 sites Viral Activation...

10.1046/j.1537-2995.2001.41081030.x article EN Transfusion 2001-08-01

Background Primary dysfunction is a failure of graft function which occurs in approximately 5% transplanted livers. Retransplantation often required. The presence elevated serum cytokines interleukin 6 and tumor necrosis factor with hepatic dysfunction, as well the historical benefit plasmapheresis fulminant failure-associated coma suggest possible role for therapy management primary liver transplantation. Design Methods: We evaluated effectiveness 18 patients who underwent orthotopic...

10.1002/(sici)1098-1101(1996)11:1<10::aid-jca2>3.0.co;2-e article EN Journal of Clinical Apheresis 1996-01-01

Five patients with anti‐Cartwright (Yt a ) in their serum were observed during 14‐month period. One of the whom 51Cr‐labeled donor red cell survival study was done showed increased destruction infused Yt ‐positive cells while three other tested greater than 85 percent at 1 hour. None antibodies potentiated interaction between sensitized and heterologous activated mononuclear cells. The fifth patient received many transfusions without any adverse reaction. Performance 1‐hour ‐ positive is...

10.1046/j.1537-2995.1985.25485273822.x article EN Transfusion 1985-07-08

No AccessJournal of UrologyUrological Survey: Abstracts1 Oct 1999Randomized Trial Comparing Packed Red Cell Blood Transfusion With and Without Leukocyte Depletion for Gastrointestinal Surgery P.I. Tartter, K. Mohandas, P. Azar, J. Endres, Kaplan, M. Spivack, Patrick C. Walsh TartterP.I. Tartter More articles by this author , MohandasK. Mohandas AzarP. Azar EndresJ. Endres KaplanJ. Kaplan SpivackM. Spivack WalshPatrick View All Author...

10.1016/s0022-5347(05)68385-1 article EN The Journal of Urology 1999-10-01

BACKGROUND: RBC transfusion is associated with fever and other reactions in some patients. The Viral Activation Transfusion Study randomly assigned patients to receive either unmodified or WBC‐reduced RBCs thus offered an opportunity assess the effect of on incidence prospectively. STUDY DESIGN AND METHODS: This prospective, randomized, double‐blind, multicenter study compared prestorage HIV‐infected, CMV‐seropositive, transfusion‐naive persons who required transfusions for anemia. Primary...

10.1046/j.1537-2995.2002.00036.x article EN Transfusion 2002-02-01

Patients with sickle cell disease (SCD) frequently undergo prophylactic red blood (RBC) exchange transfusion and simple (RCE/T) to prevent complications of disease, such as stroke. These treatment procedures are performed a target hemoglobin S (HbS) ≤30%, or goal maintaining an HbS level <30% immediately prior the next transfusion. However, there is lack evidence-based instructions for how perform RCE/T in way that will result value between treatments.To determine whether targets...

10.1002/jca.22056 article EN Journal of Clinical Apheresis 2023-05-17

Complete loss of Rho(D) antigen from red blood cells (RBCs) individuals with hematologic disorders, though not frequent, has been reported. This case reports the D on RBCs a patient acute myelogenous leukemia and its reappearance when he was in remission. Loss expression coincided worsening clinical cytogenetic disease. At time loss, also had abnormalities bone marrow cells. When remission, chromosomal were no longer detectable, his regained expression.

10.21307/immunohematology-2019-940 article EN Immunohematology 1994-01-01

Abstract Background and Objectives : Anti‐D W is a rare specificity that detects an antigen on D Va red blood cells (RBCs). Some anti‐D contain inseparable component cross‐reacts weakly with RBCs expressing the low‐incidence Rh Rh32. RH32 expressed by either R N or DBT phenotype. Case Report We describe here antibody found in serum of 2 patients reacts equally well possessing , phenotypes. The reactivity for Rh32 antigens could not be separated adsorption onto elution from +Rh32‐or...

10.1046/j.1423-0410.1998.7530230.x article EN Vox Sanguinis 1998-11-01

Anti-DW is a rare specificity that detects an antigen on DVa red blood cells (RBCs). Some anti-DW contain inseparable component cross-reacts weakly with RBCs expressing the low-incidence Rh Rh32. RH32 expressed by either R=Nor DBT phenotype.We describe here antibody found in serum of 2 patients reacts equally well possessing DVa, R=N, or phenotypes. The reactivity for DW and Rh32 antigens could not be separated adsorption onto elution from DW+Rh32- DW-Rh32+ RBCs.We suggest amino acids...

10.1159/000030992 article EN Vox Sanguinis 1998-01-01
Coming Soon ...